Evotec Net Working Capital from 2010 to 2024

EVO Stock  USD 4.78  0.13  2.65%   
Evotec SE Net Working Capital yearly trend continues to be very stable with very little volatility. Net Working Capital is likely to drop to about 421.1 M. During the period from 2010 to 2024, Evotec SE Net Working Capital quarterly data regression pattern had sample variance of 98085.7 T and median of (65,523,000). View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
438.6 M
Current Value
421.1 M
Quarterly Volatility
313.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evotec SE financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evotec SE's main balance sheet or income statement drivers, such as Other Operating Expenses of 932.9 M, Total Operating Expenses of 296.2 M or Depreciation And Amortization of 104.9 M, as well as many indicators such as Price To Sales Ratio of 3.26, Dividend Yield of 8.0E-4 or PTB Ratio of 1.67. Evotec financial statements analysis is a perfect complement when working with Evotec SE Valuation or Volatility modules.
  
Check out the analysis of Evotec SE Correlation against competitors.

Latest Evotec SE's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of Evotec SE ADR over the last few years. It is Evotec SE's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evotec SE's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

Evotec Net Working Capital Regression Statistics

Arithmetic Mean176,158,437
Geometric Mean144,537,897
Coefficient Of Variation177.79
Mean Deviation274,148,791
Median(65,523,000)
Standard Deviation313,186,338
Sample Variance98085.7T
Range841.9M
R-Value0.83
Mean Square Error33661.7T
R-Squared0.68
Significance0.0002
Slope57,804,992
Total Sum of Squares1373199.6T

Evotec Net Working Capital History

2024421.1 M
2023438.6 M
2022736 M
2021776.4 M
2020450.4 M
2019290.6 M
201853.5 M

About Evotec SE Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Evotec SE income statement, its balance sheet, and the statement of cash flows. Evotec SE investors use historical funamental indicators, such as Evotec SE's Net Working Capital, to determine how well the company is positioned to perform in the future. Although Evotec SE investors may use each financial statement separately, they are all related. The changes in Evotec SE's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Evotec SE's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Evotec SE Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Evotec SE. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital438.6 M421.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Evotec Stock

When determining whether Evotec SE ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evotec SE's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evotec Se Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evotec Se Adr Stock:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evotec SE. If investors know Evotec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evotec SE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.28)
Revenue Per Share
2.194
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0003
Return On Equity
(0.08)
The market value of Evotec SE ADR is measured differently than its book value, which is the value of Evotec that is recorded on the company's balance sheet. Investors also form their own opinion of Evotec SE's value that differs from its market value or its book value, called intrinsic value, which is Evotec SE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evotec SE's market value can be influenced by many factors that don't directly affect Evotec SE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evotec SE's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evotec SE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evotec SE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.